Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
Catherine, born with Down syndrome and Tetralogy of Fallot (TOF), a rare congenital heart condition, has regained her quality of life after undergoing a novel Venus P™ valve implantation at the ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights ...
According to researcher Anne Robertson, the bladder is not considered a particularly glamorous organ, despite hosting many of ...
Verywell Health on MSN
Ask the Expert: A Neurologist Explains the Importance of Sleep for Brain Health
A strong relationship exists between sleep and brain health. Long-term sleep disruptions can increase the risk of ...
Explore the alarming rise of early cardiac disease among corporate professionals in India, driven by long hours, stress, and ...
Enamel does not regenerate; once you lose it it's gone forever. There is currently no solution available that can effectively ...
News-Medical.Net on MSN
Single daily polypill improves heart function and quality of life in heart failure patients
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback